Cardiovascular Nuclear Medicine
J15 · Effective Oct 1, 2015
19 active Medicare policies list Z51.12, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J15
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
6 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z51.12 |
|---|---|---|
| Antiemetic Therapy | Feb 27, 2024 | Covered |
| Antineoplaston Therapy | Nov 21, 2023 | Covered |
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
| Thermography | Mar 15, 2023 | Covered |
| Policy | Effective | Status of Z51.12 |
|---|---|---|
| Thyroid Testing | Apr 15, 2026 |
JE · Effective Mar 13, 2017
JF · Effective Mar 13, 2017
National · Effective Jan 29, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Sep 27, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
National · Effective Oct 1, 2026
| Covered |
| Policy | Effective | Status of Z51.12 |
|---|---|---|
| Transthoracic Echocardiography in Adults | Sep 15, 2026 | Covered |